Number of cardiovascular diseases and risk for poor health-related quality of life (HRQoL) assessed with the European Organisation for Research and Treatment of Cancer QLQ-C30 and presented as OR with 95% CI
| Number of cardiovascular diseases*, OR (95% CI)† | ||||
|---|---|---|---|---|
| HRQoL aspects‡ | None 3552 (72%) | One 1103 (22%) | Two 172 (3%) | Three or more 83 (2%) |
| Poor global quality of life | 1.00 (reference) | 1.28 (0.90 to 1.81) | 1.81 (0.95 to 3.42) | 3.38 (1.84 to 6.21) |
| Poor physical function | 1.00 (reference) | 1.52 (1.13 to 2.04) | 3.67 (2.45 to 5.48) | 3.52 (1.74 to 7.10) |
| Poor role function | 1.00 (reference) | 1.70 (0.79 to 3.68) | 2.71 (0.95 to 7.74) | 3.16 (1.18 to 8.44) |
| Poor emotional function | 1.00 (reference) | 0.86 (0.62 to 1.20) | 1.24 (0.70 to 2.20) | 1.44 (0.79 to 2.64) |
| Symptomatic fatigue | 1.00 (reference) | 1.09 (0.80 to 1.49) | 3.69 (2.32 to 5.87) | 3.66 (1.87 to 7.18) |
| Symptomatic dyspnoea | 1.00 (reference) | 1.37 (1.08 to 1.74) | 4.81 (3.24 to 7.13) | 4.18 (2.24 to 7.80) |
Frequency weighted for age and sex to match the national distribution in Sweden.
*Cardiovascular disease: Angina, atrial fibrillation, heart failure, hypertension or earlier myocardial infarction. Due to missing data, the percentages do not add up to 100%.
†Adjusted for age, sex, education, comorbidity, tobacco smoking and physical activity.
‡Poor or symptomatic: At least one response of ‘quite a bit’ or ‘very much’ to an item within a scale (physical, role and emotional function, fatigue and dyspnoea) or at least one response of 1-4 to one of the items in the global quality-of-life scale.